CDC42 and RAC2 |
cell division cycle 42 |
Rac family small GTPase 2 |
- GPVI-mediated activation cascade
- EGFR downregulation
- Rho GTPase cycle
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- CD28 dependent Vav1 pathway
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- DCC mediated attractive signaling
- Inactivation of CDC42 and RAC1
- VEGFA-VEGFR2 Pathway
- Myogenesis
- Myogenesis
- RHO GTPases activate KTN1
- RHO GTPases activate IQGAPs
- RHO GTPases activate PAKs
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate Formins
- RHO GTPases Activate Formins
- MAPK6/MAPK4 signaling
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
- G beta:gamma signalling through CDC42
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
- Factors involved in megakaryocyte development and platelet production
|
- GPVI-mediated activation cascade
- ROS and RNS production in phagocytes
- PIP3 activates AKT signaling
- Rho GTPase cycle
- Constitutive Signaling by Aberrant PI3K in Cancer
- PCP/CE pathway
- RHO GTPases Activate NADPH Oxidases
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
- Aminophosphonic Acid-Guanylate Ester
- Guanosine-5'-Diphosphate
|
|
|
- Leukocyte adhesion deficiency (LAD), including the following four diseases: Leukocyte adhesion deficiency (I); Leukocyte adhesion deficiency (II); Leukocyte adhesion deficiency (III); LAD with Rac2 deficiency
|
CDH2 and GRIN1 |
cadherin 2 |
glutamate ionotropic receptor NMDA type subunit 1 |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Adherens junctions interactions
- Myogenesis
- Myogenesis
- Post-translational protein phosphorylation
|
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- RAF/MAP kinase cascade
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- Assembly and cell surface presentation of NMDA receptors
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
|
- Glutamic Acid
- Atomoxetine
- Pentobarbital
- Secobarbital
- Pethidine
- Acamprosate
- Gabapentin
- Memantine
- Orphenadrine
- Phenobarbital
- Prasterone
- Dcka, 5,7-Dichlorokynurenic Acid
- D-Serine
- Cycloleucine
- Milnacipran
- CNS-5161
- Acetylcysteine
- Ketobemidone
- Gavestinel
- Agmatine
- Ifenprodil
- Magnesium acetate tetrahydrate
- Magnesium carbonate
- Fluciclovine (18F)
|
|
|
CDH2 and CDH4 |
cadherin 2 |
cadherin 4 |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Adherens junctions interactions
- Myogenesis
- Myogenesis
- Post-translational protein phosphorylation
|
- Adherens junctions interactions
- Myogenesis
- Myogenesis
|
|
|
|
|
CDH4 and MTNR1B |
cadherin 4 |
melatonin receptor 1B |
- Adherens junctions interactions
- Myogenesis
- Myogenesis
|
- Class A/1 (Rhodopsin-like receptors)
- G alpha (i) signalling events
|
|
- Ramelteon
- Melatonin
- Resveratrol
- Agomelatine
- Tasimelteon
|
|
- Type II diabetes mellitus
|
CDH4 and UBE2I |
cadherin 4 |
ubiquitin conjugating enzyme E2 I |
- Adherens junctions interactions
- Myogenesis
- Myogenesis
|
- Meiotic synapsis
- Vitamin D (calciferol) metabolism
- SUMO is transferred from E1 to E2 (UBE2I, UBC9)
- SUMO is transferred from E1 to E2 (UBE2I, UBC9)
- SUMOylation of DNA damage response and repair proteins
- SUMO E3 ligases SUMOylate target proteins
- SUMOylation of transcription factors
- SUMOylation of transcription factors
- SUMOylation of ubiquitinylation proteins
- SUMOylation of transcription cofactors
- SUMOylation of transcription cofactors
- SUMOylation of SUMOylation proteins
- SUMOylation of intracellular receptors
- SUMOylation of intracellular receptors
- SUMOylation of chromatin organization proteins
- SUMOylation of chromatin organization proteins
- SUMOylation of RNA binding proteins
- SUMOylation of DNA replication proteins
- SUMOylation of DNA replication proteins
- SUMOylation of DNA methylation proteins
- SUMOylation of DNA methylation proteins
- SUMOylation of immune response proteins
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Processing of DNA double-strand break ends
- Formation of Incision Complex in GG-NER
- Negative regulation of activity of TFAP2 (AP-2) family transcription factors
- Negative regulation of activity of TFAP2 (AP-2) family transcription factors
- Postmitotic nuclear pore complex (NPC) reformation
|
|
|
|
|
CDK6 and PPARGC1A |
cyclin dependent kinase 6 |
PPARG coactivator 1 alpha |
- Oxidative Stress Induced Senescence
- Senescence-Associated Secretory Phenotype (SASP)
- Oncogene Induced Senescence
- Cyclin D associated events in G1
- Regulation of RUNX1 Expression and Activity
- Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
- Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
|
- PPARA activates gene expression
- Transcriptional activation of mitochondrial biogenesis
- Activation of PPARGC1A (PGC-1alpha) by phosphorylation
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- SUMOylation of transcription cofactors
- Circadian Clock
- Circadian Clock
- Regulation of RUNX2 expression and activity
- Regulation of RUNX2 expression and activity
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
|
- Alvocidib
- (2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol
- 3,7,3',4'-TETRAHYDROXYFLAVONE
- Palbociclib
- Ribociclib
- Abemaciclib
|
|
|
|
CDK9 and GRN |
cyclin dependent kinase 9 |
granulin precursor |
- Formation of RNA Pol II elongation complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- Interactions of Tat with host cellular proteins
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA polymerase II transcribes snRNA genes
- RNA polymerase II transcribes snRNA genes
- RNA Polymerase II Transcription Elongation
- Estrogen-dependent gene expression
|
|
|
|
|
- Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
|
CDKN1B and YWHAZ |
cyclin dependent kinase inhibitor 1B |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
- SCF(Skp2)-mediated degradation of p27/p21
- AKT phosphorylates targets in the cytosol
- Senescence-Associated Secretory Phenotype (SASP)
- DNA Damage/Telomere Stress Induced Senescence
- RHO GTPases activate CIT
- Constitutive Signaling by AKT1 E17K in Cancer
- TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- Cyclin D associated events in G1
- p53-Dependent G1 DNA Damage Response
- Cyclin A:Cdk2-associated events at S phase entry
- PTK6 Regulates Cell Cycle
- FOXO-mediated transcription of cell cycle genes
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
|
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Deactivation of the beta-catenin transactivating complex
- Rap1 signalling
- GP1b-IX-V activation signalling
- KSRP (KHSRP) binds and destabilizes mRNA
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- NOTCH4 Activation and Transmission of Signal to the Nucleus
- Negative regulation of NOTCH4 signaling
- Regulation of localization of FOXO transcription factors
|
|
|
|
|
CDKN1C and NR4A2 |
cyclin dependent kinase inhibitor 1C |
nuclear receptor subfamily 4 group A member 2 |
- Cyclin D associated events in G1
|
- Nuclear Receptor transcription pathway
- SUMOylation of intracellular receptors
|
|
|
- Beckwith-Wiedemann syndrome
- Adrenal carcinoma
|
|
CDKN2D and NR4A2 |
cyclin dependent kinase inhibitor 2D |
nuclear receptor subfamily 4 group A member 2 |
- Oxidative Stress Induced Senescence
- Senescence-Associated Secretory Phenotype (SASP)
- Oncogene Induced Senescence
- Cyclin D associated events in G1
|
- Nuclear Receptor transcription pathway
- SUMOylation of intracellular receptors
|
|
|
|
|
CDR2 and NDN |
cerebellar degeneration related protein 2 |
necdin, MAGE family member |
|
- Interleukin-4 and Interleukin-13 signaling
|
|
|
|
- Prader-Willi and Angelman syndromes, including: Angelman syndrome (AS); Prader-Willi syndrome (PWS)
|
CDX4 and HOXA5 |
caudal type homeobox 4 |
homeobox A5 |
|
|
|
|
|
|
CEACAM5 and UQCC2 |
CEA cell adhesion molecule 5 |
ubiquinol-cytochrome c reductase complex assembly factor 2 |
- Post-translational modification: synthesis of GPI-anchored proteins
- Cell surface interactions at the vascular wall
|
|
- S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate
|
|
|
|
CENPE and TRAF4 |
centromere protein E |
TNF receptor associated factor 4 |
- Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
- MHC class II antigen presentation
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- RHO GTPases Activate Formins
- COPI-dependent Golgi-to-ER retrograde traffic
- Mitotic Prometaphase
- EML4 and NUDC in mitotic spindle formation
- Kinesins
|
|
|
|
|
|
CETN3 and LMNA |
centrin 3 |
lamin A/C |
|
- XBP1(S) activates chaperone genes
- Signaling by BRAF and RAF fusions
|
|
|
|
- Restrictive dermopathy
- Emery-Dreifuss muscular dystrophy
- Dilated cardiomyopathy (DCM)
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
- Mandibuloacral dysplasia
- Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
- Limb-girdle muscular dystrophy (LGMD)
- Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
- Hutchinson-Gilford progeria syndrome
|
CFL1 and YWHAZ |
cofilin 1 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
- Platelet degranulation
- Regulation of actin dynamics for phagocytic cup formation
- EPHB-mediated forward signaling
- Sema3A PAK dependent Axon repulsion
- RHO GTPases Activate ROCKs
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Deactivation of the beta-catenin transactivating complex
- Rap1 signalling
- GP1b-IX-V activation signalling
- KSRP (KHSRP) binds and destabilizes mRNA
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- NOTCH4 Activation and Transmission of Signal to the Nucleus
- Negative regulation of NOTCH4 signaling
- Regulation of localization of FOXO transcription factors
|
- Lauryl Dimethylamine-N-Oxide
- Copper
- Artenimol
|
|
|
|
CGB3 and NLGN3 |
chorionic gonadotropin subunit beta 3 |
neuroligin 3 |
- Glycoprotein hormones
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
|
- Neurexins and neuroligins
- Neurexins and neuroligins
|
|
|
|
|
CHGB and TAZ |
chromogranin B |
tafazzin |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
- Mitochondrial protein import
- Mitochondrial protein import
- Acyl chain remodeling of CL
|
|
|
|
- 3-Methylglutaconic aciduria (MGCA)
- Barth syndrome (BTHS)
- Dilated cardiomyopathy (DCM)
|
CHGB and RAC2 |
chromogranin B |
Rac family small GTPase 2 |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
- GPVI-mediated activation cascade
- ROS and RNS production in phagocytes
- PIP3 activates AKT signaling
- Rho GTPase cycle
- Constitutive Signaling by Aberrant PI3K in Cancer
- PCP/CE pathway
- RHO GTPases Activate NADPH Oxidases
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
|
|
|
- Leukocyte adhesion deficiency (LAD), including the following four diseases: Leukocyte adhesion deficiency (I); Leukocyte adhesion deficiency (II); Leukocyte adhesion deficiency (III); LAD with Rac2 deficiency
|
CHM and RAB3A |
CHM Rab escort protein |
RAB3A, member RAS oncogene family |
- TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
- RAB geranylgeranylation
- RAB GEFs exchange GTP for GDP on RABs
|
- Serotonin Neurotransmitter Release Cycle
- Norepinephrine Neurotransmitter Release Cycle
- Glutamate Neurotransmitter Release Cycle
- Dopamine Neurotransmitter Release Cycle
- Acetylcholine Neurotransmitter Release Cycle
- Neutrophil degranulation
- RAB geranylgeranylation
- RAB GEFs exchange GTP for GDP on RABs
- GABA synthesis, release, reuptake and degradation
|
|
|
- Choroideremia (CHM); Tapetochoroidal dystrophy
|
|